The investigation concerns whether Idenix’s board of directors failed to adequately shop the Company and obtain the best possible value for Idenix’s shareholders before entering into an agreement with Merck.
** By golly - a lawsuit because people feel that they didn't get proper value. Now there's a group that didn't just "take it" !!!
It's all good. Glad you pointed that out as this could be the same situation for Titan medical. I have a strong position in a another bio stock that will be exactly like the company bought by Merck. Look at MNKD. They are close to getting FDA approval on their diabetes drug.
News 
Market Data 
Discover 
